Congenital Chylothorax and Hydrops Fetalis: A Novel Neonatal Presentation of RASA1 Mutation.
Alessia Gallipoli, Gillian MacLean, Jagdeep S Walia...
https://pubmed.ncbi.nlm.nih.gov/33608416/Actively Recruiting
Led by Ataturk University · Updated on 2026-05-12
60
Participants Needed
1
Research Sites
12 weeks
Total Duration
Researchers are comparing two local anesthetic methods for ultrasound-guided popliteal sciatic nerve block in adults aged 18 to 65 undergoing elective distal lower leg surgery. This study focuses on how quickly sensory and motor blockades begin and evaluates several postoperative outcomes such as pain levels, opioid use, and recovery quality. The trial is conducted at Ataturk University Research Hospital in Turkey with 60 participants divided into two groups. Participants will receive one of two treatments before surgery one group gets a combination of lidocaine and bupivacaine, while the other group receives bupivacaine alone. Both treatments involve 20 mL total volume administered via ultrasound guidance to the popliteal sciatic nerve. Some patients may also receive an additional adductor canal block. During surgery, sedation and vital signs are carefully monitored, and standardized postoperative pain relief is provided. Throughout the study, researchers will assess block onset time, success rates, duration of sensory and motor block, and pain scores at multiple time points up to 24 hours after surgery. They will also monitor opioid use, quality of recovery, and any rebound pain. Neurological assessments are performed one week after surgery to check for any nerve issues. The study uses a double-blind design, with patients and outcome assessors unaware of the treatment group.
CONDITIONS
Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block
A
AHMET MURAT YAYIK, MD, PhD
A
ASLIHAN BOROGLU, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ataturk University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day
Participants receive an ultrasound-guided popliteal sciatic nerve block with either a bupivacaine-lidocaine combination or bupivacaine alone before elective lower extremity surgery.
1 visit (in-person) for block administration and surgery
Duration - Up to 7 days postoperatively
Participants are monitored for pain levels, opioid consumption, block duration, and neurological status following the nerve block and surgery.
Multiple visits including assessments at 2, 4, 8, 12, and 24 hours postoperatively and a neurological assessment at postoperative day 7
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alessia Gallipoli, Gillian MacLean, Jagdeep S Walia...
https://pubmed.ncbi.nlm.nih.gov/33608416/Bracha Wieder, Jaime Arbisfeld
https://pubmed.ncbi.nlm.nih.gov/37882382/Giovanni Occhipinti, Andrea Alberto Ruberti, Jorge Alcocer...
https://pubmed.ncbi.nlm.nih.gov/39922556/Ataturk University
Lead Sponsor